Near-Infrared Intraoperative Imaging Can Successfully Identify Malignant Pleural Mesothelioma After Neoadjuvant Chemotherapy
Malignant pleural mesothelioma is a deadly disease. Complete surgical resection provides patients with the best opportunity for long-term survival. Unfortunately, identification of disease during resection can be challenging. In this report, we describe successful intraoperative utilization of the n...
Saved in:
| Main Authors: | Jarrod D. Predina MD, MTR, Andrew Newton MD, Greg Kennedy BA, M. Kenneth Lee MD, PhD, Sunil Singhal MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-08-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.1177/1536012117723785 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment
by: Sabine Schmid, MD, et al.
Published: (2024-12-01) -
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system
by: Wenwang Lang, et al.
Published: (2025-01-01) -
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
by: Prashasti Agrawal, MD, et al.
Published: (2025-01-01) -
The presence of pleural effusion is an independent prognostic factor in patients with malignant pleural mesothelioma
by: Haoyu Wang, et al.
Published: (2025-01-01) -
Malignant Pleural Mesothelioma. Case Report and Literature Review
by: Samuel Sánchez Sánchez, et al.
Published: (2020-10-01)